News und Analysen
Clovis Oncology to Highlight Data for its Three Portfolio Compounds at the ESMO Virtual Congress 2020
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that six e-posters highlighting clinical data from the lucitanib and Rubraca® (rucaparib) clinical development programs, as well as preclinical
Xencor to Present Initial Data from the Phase 1 Study of Tidutamab in Neuroendocrine Tumors at NANETS’ Multidisciplinary NET Medical Virtual Symposium
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced that initial
Pfizer and BioNTech Announce Data from Preclinical Studies of mRNA-based Vaccine Candidate Against COVID-19
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced preliminary preclinical data in mouse and non-human primate models from their BNT162b2 mRNA-based vaccine program against
NanoString Announces New GeoMx COVID-19 Consortium, Part of the GeoMx Translational Leadership Network
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the formation of the GeoMx Translational Leadership
Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
Pfizer (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that they had concluded exploratory talks with the European Commission for a proposed supply of 200 million doses of their
Albireo Pharma: SD-Jubiläumsrakete liefert +115%
Unsere Jubiläumsrakete Albireo Pharma (WKN: A2DF99) knallte gestern dank positiver Studienergebnisse auf bis zu 49,00 US-Dollar und damit 115% auf unseren Empfehlungskurs von 22,78 US-Dollar – was
Sirona Biochem beauftragt WuXi AppTec mit der Herstellung von TFC-1067 im Großmaßstab
Vancouver, British Columbia – 9. September 2020 – Sirona Biochem Corp. (TSX-V: SBM) (FWB: ZSB) (US-OTC: SRBCF) („Sirona“) freut sich bekannt zu geben, dass das Unternehmen eine Vereinbarung
Sirona Biochem Contracts WuXi AppTec for Large-Scale Manufacturing of TFC-1067
Vancouver, British Columbia – September 9, 2020 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce it has signed an agreement with Contract Manuf
Puma Biotechnology to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of
Clovis Oncology to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its President and Chief Executive Officer, Patrick J. Mahaffy, will present at the H.C. Wainwright 22nd Annual Global Investment Conference
QIAGEN führt portablen Schnelltest ein, der mehr als 30 Proben pro Stunde auf das SARS-CoV-2-Antigen untersuchen kann
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute Pläne zur Einführung eines portablen Schnelltests bekannt gegeben, der mittels eines kleinen digitalen Testsystems SARS-CoV-2-Antigene
Navidea Biopharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today
QIAGEN to Launch Rapid Portable Test That Can Analyze Over 30 Samples Per Hour for SARS-CoV-2 Antigen
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to launch a rapid portable test that can detect SARS-CoV-2 antigens in people with active infections in less than 15 minutes
Positive Initial Data From a Phase 1 Trial With Transgene’s Oncolytic Virus TG6002
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces first positive data from the Phase
Charles River Laboratories to Present at September Investor Conferences
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at three upcoming investor conferences, including:
-
Wells Fargo 2020 Healthcare
Savara Announces New England Journal of Medicine (NEJM) Publication of IMPALA Study Results
Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today announced that results from the Phase 3 IMPALA study were published online in NEJM. The manuscript, titled “Inhaled Molgramostim
Biopharma Leaders Unite to Stand with Science
The CEOs of AstraZeneca (LSE/STO/NYSE: AZN), BioNTech (NASDAQ: BNTX), GlaxoSmithKline plc (LSE/NYSE: GSK), Johnson & Johnson (NYSE: JNJ), Merck (NYSE: MRK), known as MSD outside the United States
Canopy Growth: Neuer Online-Store, aber bekannte Zahlenschwäche...
Canopy Growth (WKN: A140QA) goes online: Mit dem neuen Online-Store ShopCanopy versucht das Unternehmen aus Smith Falls, Kanada, seine E-Commerce-Aktivitäten zu intensivieren.
Doch bei einem
THERANEXUS : DECLARATION OF TOTAL NUMBER OF SHARES AND VOTING RIGHTS
Lyon, September 7, 2020 – Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating the interaction
CO.DON AG: Treatment of patients starts in Switzerland
Berlin / Teltow / Leipzig, 07 September 2020 – The INSELSPITAL in Bern, Bern’s university hospital, has become the first Swiss clinic to start treating patients with the 100% autologous
CO.DON AG: Behandlung von Patienten in der Schweiz begonnen
Berlin / Teltow / Leipzig, 07. September 2020 – Das INSELSPITAL Bern, Universitätsspital der Universität Bern hat als erste Schweizer Klinik mit der Behandlung von Patienten mit dem 100 %
Relay & Fio Corp. prüfen Marktentwicklung und COVID-19-Anwendungen für Fionet
- Regierung, Medien und Ärzte stimmen sich über die Notwendigkeit von routinemäßigen, kontrollierten Tests an Flughäfen, Arbeitsplätzen, zu Hause und an anderen dezentralen Orten
Relay & Fio Corp. Address Market Development and Fionet COVID-19 Applications
- Government, Media, and Doctors Are Aligning on Need for Routine, Controlled Testing at Airports, Workplaces, Homes, and Other Decentralized Locations
- Health Canada
Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today
NANOBIOTIX Announces Half-year Financial Statements as at June 30, 2020
Regulatory News:
NANOBIOTIX (Paris:NANO) (Euronext : NANO – ISIN: FR0011341205 – the ‘‘Company’’), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer